{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:13:31Z","timestamp":1791825211596,"version":"4.3.4"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007839","name":"Yunnan University","doi-asserted-by":"crossref","award":["KC-23236563"],"award-info":[{"award-number":["KC-23236563"]}],"id":[{"id":"10.13039\/501100007839","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82273460, 82273089 and 32260167"],"award-info":[{"award-number":["82273460, 82273089 and 32260167"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Yunnan Fundamental Research Projects","award":["202401AS070133 and 202401AS070634"],"award-info":[{"award-number":["202401AS070133 and 202401AS070634"]}]},{"name":"Key Laboratory of Tumor Immunological Prevention and Treatment in Yunnan Province, Yan'an Hospital Affiliated to Kunming Medical University","award":["KLTIPT-2023-02 and KLTIPT-2023-03"],"award-info":[{"award-number":["KLTIPT-2023-02 and KLTIPT-2023-03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s13402-025-01064-7","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:14:08Z","timestamp":1747739648000},"page":"885-897","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hepatocyte nuclear factor 4-Alpha: a key regulator in liver carcinogenesis"],"prefix":"10.1007","volume":"48","author":[{"given":"Hayam","family":"Hamdy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiashun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Die","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"1064_CR1","doi-asserted-by":"publisher","unstructured":"P. Konyn, A. Ahmed, D. Kim, Current epidemiology in hepatocellular carcinoma. Expert Rev. Gastroenterol. Hepatol. 15, 1295\u20131307 (2021). https:\/\/doi.org\/10.1080\/17474124.2021.1991792","DOI":"10.1080\/17474124.2021.1991792"},{"key":"1064_CR2","doi-asserted-by":"publisher","unstructured":"Z. Li, N. Zhang, Z. Dong, X. Wang, J. Zhou, J. Gao, Y. Yang, J. Li, F. Guan, Y. Zhou, Z. Tan, Integrating transcriptomics, glycomics and glycoproteomics to characterize hepatitis B virus-associated hepatocellular carcinoma. Cell. Commun. Signal. 22, 200\u2013215 (2024). https:\/\/doi.org\/10.1186\/s12964-024-01569-y","DOI":"10.1186\/s12964-024-01569-y"},{"key":"1064_CR3","doi-asserted-by":"publisher","unstructured":"L. Sang, X. Wang, W. Bai, J. Shen, Y. Zeng, J. Sun, The role of hepatocyte nuclear factor 4\u03b1 (HNF4\u03b1) in tumorigenesis. Front. Oncol. 12, 1011230\u20131011237 (2022). https:\/\/doi.org\/10.3389\/fonc.2022.1011230","DOI":"10.3389\/fonc.2022.1011230"},{"key":"1064_CR4","doi-asserted-by":"publisher","unstructured":"D. Suresh, A.N. Srinivas, D.P. Kumar, Etiology of hepatocellular carcinoma: special focus on fatty liver disease. Front. Oncol. 10, 601710\u2013601719 (2020). https:\/\/doi.org\/10.3389\/fonc.2020.601710","DOI":"10.3389\/fonc.2020.601710"},{"key":"1064_CR5","doi-asserted-by":"publisher","unstructured":"E. Haque, A.S. Teeli, D. Winiarczyk, M. Taguchi, S. Sakuraba, H. Kono, P. Leszczy\u0144ski, M. Pierzcha\u0142a, H. Taniguchi, HNF1A POU domain mutations found in Japanese liver Cancer patients cause downregulation of HNF4A promoter activity with possible disruption in transcription networks. Genes 13, 413\u2013434 (2022). https:\/\/doi.org\/10.3390\/genes13030413","DOI":"10.3390\/genes13030413"},{"key":"1064_CR6","doi-asserted-by":"publisher","unstructured":"B.J. Lambert, E. Levesque, D. Boisvert, F. Boudreau, A244 role of the nuclear receptor hnf4\u03b1 and its many isoforms in colorectal cancer. J. Can. Association Gastroenterol. 1, 356\u2013357 (2018). https:\/\/doi.org\/10.1093\/jcag\/gwy009.244","DOI":"10.1093\/jcag\/gwy009.244"},{"key":"1064_CR7","doi-asserted-by":"publisher","unstructured":"P. Fang, W.A. Orellana, B. Abstract, Characterizing the role of HNF4\u03b1 P1 and P2 isoforms in the classical subtype of pancreatic ductal adenocarcinoma. Cancer Research. 82, B034-B034 (2022). https:\/\/doi.org\/10.1158\/1538-7445.Panca22-b034","DOI":"10.1158\/1538-7445.Panca22-b034"},{"key":"1064_CR8","doi-asserted-by":"publisher","unstructured":"T. Tanaka, S. Jiang, H. Hotta, K. Takano, H. Iwanari, K. Sumi, K. Daigo, R. Ohashi, M. Sugai, C. Ikegame, H. Umezu, Y. Hirayama, Y. Midorikawa, Y. Hippo, A. Watanabe, Y. Uchiyama, G. Hasegawa, P.C. Reid, H. Aburatani, T. Hamakubo, J. Sakai, M. Naito, T. Kodama, Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer. J Pathol. 5, 662\u2013672 (2006). https:\/\/doi.org\/10.1002\/path.1928","DOI":"10.1002\/path.1928"},{"key":"1064_CR9","doi-asserted-by":"publisher","unstructured":"S. Wilson, J. Babeu, F. Boisvert, F. Boudreau, A242 the p2 isoform class of the transcription factor hnf4a plays Dna repair role in colorectal cancer. J. Can. Assoc. Gastroenterol. 1, 423\u2013424 (2018). https:\/\/doi.org\/10.1093\/jcag\/gwy008.243","DOI":"10.1093\/jcag\/gwy008.243"},{"key":"1064_CR10","doi-asserted-by":"crossref","unstructured":"A.L. Hunter, T.M. Poolman, D. Kim, F.J. Gonzalez, D.A. Bechtold, A.S.I. Loudon, M. Iqbal, D.W. Ray, HNF4A modulates glucocorticoid action in the liver. Cell. Rep. 39, 110697","DOI":"10.1016\/j.celrep.2022.110697"},{"key":"1064_CR11","doi-asserted-by":"publisher","unstructured":"L. Zheng, M. Ji, H. Zhang, L. Chang, Regulatory mechanisms of mechanotransduction in genome instability. Genome Instability Disease. 3, 311\u2013316 (2022). https:\/\/doi.org\/10.1007\/s42764-022-00086-x","DOI":"10.1007\/s42764-022-00086-x"},{"key":"1064_CR12","doi-asserted-by":"publisher","unstructured":"S. Matsuo, M. Ogawa, M.U. Muckenthaler, Y. Mizui, S. Sasaki, T. Fujimura, M. Takizawa, N. Ariga, H. Ozaki, M. Sakaguchi, F.J. Gonzalez, Y. Inoue, Hepatocyte nuclear factor 4\u03b1 controls Iron metabolism and regulates transferrin receptor 2 in mouse liver. 290, 30855\u201330865 (2015). https:\/\/doi.org\/10.1074\/jbc.M115.694414","DOI":"10.1074\/jbc.M115.694414"},{"key":"1064_CR13","doi-asserted-by":"publisher","unstructured":"E. Thymiakou, M. Tzardi, D. Kardassis, Impaired hepatic glucose metabolism and liver-\u03b1-cell axis in mice with liver-specific ablation of the Hepatocyte Nuclear Factor 4\u03b1 (Hnf4a) gene. Metabolism: clinical and experimental. 139, 155371 (2023). https:\/\/doi.org\/10.1016\/j.metabol.2022.155371","DOI":"10.1016\/j.metabol.2022.155371"},{"key":"1064_CR14","doi-asserted-by":"publisher","unstructured":"M. Osanai, H. Chiba, T. Kojima, M. Fujibe, K. Kuwahara, H. Kimura, M. Satoh, N. Sawada, Hepatocyte nuclear factor (HNF)-4alpha induces expression of endothelial Fas ligand (FasL) to prevent cancer cell transmigration: a novel defense mechanism of endothelium against cancer metastasis. Japanese J. cancer Research: Gann. 93, 532\u2013541 (2002). https:\/\/doi.org\/10.1111\/j.1349-7006.2002.tb01288.x","DOI":"10.1111\/j.1349-7006.2002.tb01288.x"},{"key":"1064_CR15","doi-asserted-by":"publisher","unstructured":"C. Cicchini, D. Filippini, S. Coen, A. Marchetti, C. Cavallari, I. Laudadio, F.M. Spagnoli, T. Alonzi, M. Tripodi, Snail controls differentiation of hepatocytes by repressing HNF4alpha expression. J. Cell. Physiol. 209, 230\u2013238 (2006). https:\/\/doi.org\/10.1002\/jcp.20730","DOI":"10.1002\/jcp.20730"},{"key":"1064_CR16","doi-asserted-by":"publisher","unstructured":"M. Kotulkar, D.R. Robarts, U. Apte, HNF4\u03b1 in hepatocyte health and disease. Semin Liver Dis. 43, 234\u2013244 (2023). https:\/\/doi.org\/10.1055\/a-2097-0660","DOI":"10.1055\/a-2097-0660"},{"key":"1064_CR17","doi-asserted-by":"publisher","unstructured":"C. Walesky, W. Goessling, A. Balancing Act, Role of HNF4\u03b1 and \u0392 -catenin in hepatobiliary development and cholangiocarcinoma pathogenesis. The FASEB journal. 30, 56.54\u201356.54 (2016). https:\/\/doi.org\/10.1096\/fasebj.30.1_supplement.56.4","DOI":"10.1096\/fasebj.30.1_supplement.56.4"},{"key":"1064_CR18","doi-asserted-by":"publisher","unstructured":"S. Wattanavanitchakorn, P. Rojvirat, T. Chavalit, M.J. Macdonald, S. Jitrapakdee, CCAAT-enhancer binding protein-\u03b1 (C\/EBP\u03b1) and hepatocyte nuclear factor 4\u03b1 (HNF4\u03b1) regulate expression of the human fructose-1,6-bisphosphatase 1 (FBP1) gene in human hepatocellular carcinoma HepG2 cells. PLoS One 13, e0194252\u2013e0194272 (2018). https:\/\/doi.org\/10.1371\/journal.pone.0194252","DOI":"10.1371\/journal.pone.0194252"},{"key":"1064_CR19","doi-asserted-by":"publisher","unstructured":"L. Santangelo, A. Marchetti, C. Cicchini, A. Conigliaro, B. Conti, C. Mancone, J.A. Bonzo, F.J. Gonzalez, T. Alonzi, L. Amicone, M. Tripodi, The stable repression of mesenchymal program is required for hepatocyte identity: a novel role for hepatocyte nuclear factor 4\u03b1. Hepatol. (Baltimore Md) 53 2063\u20132074 (2011). https:\/\/doi.org\/10.1002\/hep.24280","DOI":"10.1002\/hep.24280"},{"key":"1064_CR20","doi-asserted-by":"publisher","unstructured":"Q. Huang, M. Pu, G. Zhao, B. Dai, Z. Bian, H. Tang, C. Chen, W. Liu, X. Qu, L. Shen, K. Tao, Tg737 regulates epithelial-mesenchymal transition and cancer stem cell properties via a negative feedback circuit between snail and HNF4\u03b1 during liver stem cell malignant transformation. Cancer Lett. 402, 52\u201360 (2017). https:\/\/doi.org\/10.1016\/j.canlet.2017.05.005","DOI":"10.1016\/j.canlet.2017.05.005"},{"key":"1064_CR21","doi-asserted-by":"publisher","unstructured":"C. Battistelli, G. Sabarese, L. Santangelo, C. Montaldo, F.J. Gonzalez, M. Tripodi, C. Cicchini, The LncRNA HOTAIR transcription is controlled by HNF4\u03b1-induced chromatin topology modulation. Cell. Death Differ. 26, 890\u2013901 (2019). https:\/\/doi.org\/10.1038\/s41418-018-0170-z","DOI":"10.1038\/s41418-018-0170-z"},{"key":"1064_CR22","doi-asserted-by":"publisher","unstructured":"J. Kuang, T. Duan, C. Gao, C. Liu, S. Chen, L.Y. Zhu, L. Min, C. Lu, W. Wang, L. Zhu, RNF8 depletion attenuates hepatocellular carcinoma progression by inhibiting epithelial-mesenchymal transition and enhancing drug sensitivity. Acta Biochim. Et Biophys. Sinica. 55, 661\u2013671 (2023). https:\/\/doi.org\/10.3724\/abbs.2023076","DOI":"10.3724\/abbs.2023076"},{"key":"1064_CR23","doi-asserted-by":"publisher","unstructured":"B. Shokouhian, B. Negahdari, Z. Heydari, M. Totonchi, H. Aboulkheyr Es, A. Piryaei, E. Mostafavi, M. Vosough, HNF4\u03b1 is possibly the missing link between epithelial-mesenchymal transition and Warburg effect during hepatocarcinogenesis. Cancer Sci. 114, 1337\u20131352 (2023). https:\/\/doi.org\/10.1111\/cas.15686","DOI":"10.1111\/cas.15686"},{"key":"1064_CR24","doi-asserted-by":"publisher","unstructured":"A.S. Teeli, K. \u0141uczy\u0144ska, E. Haque, M.A. Gayas, D. Winiarczyk, H. Taniguchi, Disruption of tumor suppressors HNF4\u03b1\/HNF1\u03b1 causes tumorigenesis in liver. Cancers. 13, 5357\u20133578 (2021). https:\/\/doi.org\/10.3390\/cancers13215357","DOI":"10.3390\/cancers13215357"},{"key":"1064_CR25","doi-asserted-by":"publisher","unstructured":"F. Lin, W. Zhou, X. Yuan, S. Liu, Z. He, Mechanistic study of Quercetin in the treatment of hepatocellular carcinoma with diabetes via MEK\/ERK pathway. Int. Immunopharmacol. 142, 113194 (2024). https:\/\/doi.org\/10.1016\/j.intimp.2024.113194","DOI":"10.1016\/j.intimp.2024.113194"},{"key":"1064_CR26","doi-asserted-by":"publisher","unstructured":"H. Chen, Q. Wu, L. Peng, T. Cao, M.-L. Deng, Y.-W. Liu, J. Huang, Y. Hu, N. Fu, K.-B. Zhou, M.-L. Yang, X.-F. Yang, S. Tan, Mechanism, Clinical Significance, and Treatment Strategy of Warburg Effect in Hepatocellular Carcinoma. Journal of Nanomaterials. 2021, 1\u201310 (2021). https:\/\/doi.org\/10.1155\/2021\/5164100","DOI":"10.1155\/2021\/5164100"},{"key":"1064_CR27","doi-asserted-by":"publisher","unstructured":"Q. Xu, Y. Li, X. Gao, K. Kang, J.G. Williams, L. Tong, J. Liu, M. Ji, L.J. Deterding, X. Tong, J.W. Locasale, L. Li, I. Shats, X. Li, HNF4\u03b1 regulates sulfur amino acid metabolism and confers sensitivity to methionine restriction in liver cancer. Nat. Commun. 1, 3978\u20133995 (2020). https:\/\/doi.org\/10.1038\/s41467-020-17818-w","DOI":"10.1038\/s41467-020-17818-w"},{"key":"1064_CR28","doi-asserted-by":"publisher","unstructured":"X. Wang, J. Shi, M. Huang, J. Chen, J. Dan, Y. Tang, Z. Guo, X. He, Q. Zhao, TUBB2B facilitates progression of hepatocellular carcinoma by regulating cholesterol metabolism through targeting HNF4A\/CYP27A1. Cell death & disease. 14, 179\u2013188 (2023). https:\/\/doi.org\/10.1038\/s41419-023-05687-2","DOI":"10.1038\/s41419-023-05687-2"},{"key":"1064_CR29","doi-asserted-by":"publisher","unstructured":"G. Fu, S.T. Li, Z. Jiang, Q. Mao, N. Xiong, X. Li, Y. Hao, H. Zhang, PGAM5 deacetylation mediated by SIRT2 facilitates lipid metabolism and liver cancer proliferation. Acta Biochim. Et Biophys. Sinica. 55, 1370\u20131379 (2023). https:\/\/doi.org\/10.3724\/abbs.2023155","DOI":"10.3724\/abbs.2023155"},{"key":"1064_CR30","doi-asserted-by":"publisher","unstructured":"C. Liu, J. Shi, Z. Jiang, S. Jiang, Y. Wu, D. Peng, J. Tang, L. Guo, RP11-495P10.1 promotes HCC cell proliferation by regulating reprogramming of glucose metabolism and acetylation of the NR4A3 promoter via the PDK1\/PDH axis. Acta Biochimica et Biophysica Sinica. 56, 44\u201353. (2024). https:\/\/doi.org\/10.3724\/abbs.2023242","DOI":"10.3724\/abbs.2023242"},{"key":"1064_CR31","doi-asserted-by":"publisher","unstructured":"Y. Ni, M. Huang, S. Chen, S. Wang, J. Chen, Integrins and NAFLD-associated liver diseases: clinical associations, pathophysiological mechanisms and Pharmacological implications: integrins and NAFLD-associated liver diseases. Acta Biochim. Biophys. Sin (Shanghai) 56, 1573\u20131583 (2024). https:\/\/doi.org\/10.3724\/abbs.2024149","DOI":"10.3724\/abbs.2024149"},{"key":"1064_CR32","doi-asserted-by":"publisher","unstructured":"X. Yang, H. Feng, J. Kim, G. Ti, L. Wang, K. Wang, D. Song, PRR34-AS1 promotes mitochondrial division and glycolytic reprogramming in hepatocellular carcinoma cells through upregulation of MIEF2. Acta Biochimica et Biophysica Sinica. 56, 1604\u20131617 (2024). https:\/\/doi.org\/10.3724\/abbs.2024083","DOI":"10.3724\/abbs.2024083"},{"key":"1064_CR33","doi-asserted-by":"publisher","unstructured":"B.F. Ning, J. Ding, C. Yin, W. Zhong, K. Wu, X. Zeng, W. Yang, Y.X. Chen, J.P. Zhang, X. Zhang, H.Y. Wang, W.F. Xie, Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer research. 70, 7640\u20137651. (2010). https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-0824","DOI":"10.1158\/0008-5472.CAN-10-0824"},{"key":"1064_CR34","doi-asserted-by":"publisher","unstructured":"D.D. Lv, L.Y. Zhou, H. Tang, Hepatocyte nuclear factor 4\u03b1 and cancer-related cell signaling pathways: a promising insight into cancer treatment. Experimental Mol. Med. 53, 8\u201318 (2021). https:\/\/doi.org\/10.1038\/s12276-020-00551-1","DOI":"10.1038\/s12276-020-00551-1"},{"key":"1064_CR35","doi-asserted-by":"publisher","unstructured":"D.V.F. Tauriello, E. Batlle, Targeting the microenvironment in advanced colorectal cancer. Trends in Cancer. 2, 495\u2013504 (2016). https:\/\/doi.org\/10.1016\/j.trecan.2016.08.001","DOI":"10.1016\/j.trecan.2016.08.001"},{"key":"1064_CR36","doi-asserted-by":"publisher","unstructured":"L. Yin, H. Ma, X. Ge, P.A. Edwards, Y. Zhang, Hepatic hepatocyte nuclear factor 4\u03b1 is essential for maintaining triglyceride and cholesterol homeostasis. Arteriosclerosis, thrombosis, and vascular biology. 11, 328\u2013336 (2011). https:\/\/doi.org\/10.1161\/ATVBAHA.110.217828","DOI":"10.1161\/ATVBAHA.110.217828"},{"key":"1064_CR37","doi-asserted-by":"publisher","unstructured":"W.W. Hwang-Verslues, F.M. Sladek, HNF4\u03b1--role in drug metabolism and potential drug target? Current opinion in pharmacology. 10, 698\u2013705 (2010). https:\/\/doi.org\/10.1016\/j.coph.2010.08.010","DOI":"10.1016\/j.coph.2010.08.010"},{"key":"1064_CR38","doi-asserted-by":"publisher","unstructured":"\u00c9. Lambert, J.P. Babeu, J. Simoneau, J. Raisch, L. Lavergne, D. L\u00e9vesque, \u00c9. Jolibois, M. Avino, M.S. Scott, F. Boudreau, F.M. Boisvert, Human hepatocyte nuclear factor 4-\u03b1 encodes isoforms with distinct transcriptional functions. Molecular & Cellular Proteomics. 19, 808\u2013829 (2022). https:\/\/doi.org\/10.1074\/mcp.RA119.001909","DOI":"10.1074\/mcp.RA119.001909"},{"key":"1064_CR39","doi-asserted-by":"publisher","unstructured":"J.Y. Chiang, Hepatocyte nuclear factor 4alpha regulation of bile acid and drug metabolism. Expert Opin. Drug Metab. Toxicol. 2, 137\u2013147 (2009). https:\/\/doi.org\/10.1517\/17425250802707342","DOI":"10.1517\/17425250802707342"},{"key":"1064_CR40","doi-asserted-by":"publisher","unstructured":"C. Walesky, U. Apte, Role of hepatocyte nuclear factor 4\u03b1 (HNF4\u03b1) in cell proliferation and cancer. Gene Expression 16, 101\u2013108 (2015). https:\/\/doi.org\/10.3727\/105221615X14181438356292","DOI":"10.3727\/105221615X14181438356292"},{"key":"1064_CR41","doi-asserted-by":"publisher","unstructured":"J.H. Kim, H.J. Eom, G. Lim, S. Park, J. Lee, S. Nam, Y.H. Kim, J.H. Jeong, Differential effects, on oncogenic pathway signalling, by derivatives of the HNF4 \u03b1 inhibitor BI6015. Br. J. cancer. 120, 488\u2013498 (2019). https:\/\/doi.org\/10.1038\/s41416-018-0374-5","DOI":"10.1038\/s41416-018-0374-5"},{"key":"1064_CR42","doi-asserted-by":"publisher","unstructured":"M. Sun, X. Liu, W. Wei, N. Ge, S. Luo, S. Shen, R. Ge, BAP31 promotes proliferation, invasion, and metastasis of liver Cancer cells via activating PI3K\/AKT pathway. J. Healthc. Eng. 11, 7686728 (2022). https:\/\/doi.org\/10.1155\/2022\/7686728","DOI":"10.1155\/2022\/7686728"},{"key":"1064_CR43","doi-asserted-by":"publisher","unstructured":"E. Dang, S. Yang, C. Song, D. Jiang, Z. Li, W. Fan, Y. Sun, L. Tao, J. Wang, T. Liu, C. Zhang, B. Jin, J. Wang, K. Yang, BAP31, a newly defined cancer\/testis antigen, regulates proliferation, migration, and invasion to promote cervical cancer progression. Cell. Death Disease 9, 791\u2013112 (2018). https:\/\/doi.org\/10.1038\/s41419-018-0824-2","DOI":"10.1038\/s41419-018-0824-2"},{"key":"1064_CR44","doi-asserted-by":"publisher","unstructured":"V. Marchesin, A. P\u00e9rez-Mart\u00ed, G. Le Meur, R. Pichler, K. Grand, E.D. Klootwijk, A. Kesselheim, R. Kleta, S. Lienkamp, M. Simons, Molecular basis for Autosomal-Dominant renal Fanconi syndrome caused by HNF4A. Cell reports. 29, 4407\u20134421.e4405. (2019). https:\/\/doi.org\/10.1016\/j.celrep.2019.11.066","DOI":"10.1016\/j.celrep.2019.11.066"},{"key":"1064_CR45","doi-asserted-by":"publisher","unstructured":"A. Thakur, K. Park, R. Cullum, B.M. Fuglerud, M. Khoshnoodi, S. Drissler, T.L. Stephan, J. Lotto, D. Kim, F.J. Gonzalez, P.A. Hoodless, HNF4A guides the MLL4 complex to Establish and maintain H3K4me1 at gene regulatory elements. Commun. Biology. 7, 144\u2013158 (2024). https:\/\/doi.org\/10.1038\/s42003-024-05835-0","DOI":"10.1038\/s42003-024-05835-0"},{"key":"1064_CR46","doi-asserted-by":"publisher","unstructured":"P.H. Tsai, M.L. Wang, J.H. Chang, A.A. Yarmishyn, P.N. Nhi Nguyen, W. Chen, Y. Chien, T.I. Huo, C.Y. Mou, S.H. Chiou, dual delivery of HNF4\u03b1 and cisplatin by mesoporous silica nanoparticles inhibits Cancer pluripotency and tumorigenicity in Hepatoma-Derived CD133-Expressing stem cells. ACS Appl. Mater. Interfaces 11, 19808\u201319818 (2019). https:\/\/doi.org\/10.1021\/acsami.9b04474","DOI":"10.1021\/acsami.9b04474"},{"key":"1064_CR47","doi-asserted-by":"publisher","unstructured":"Z. Wang, Y. Zhang, J. Zhang, Q. Deng, H. Liang, Controversial roles of hepatocyte nuclear receptor 4 \u03b1 on tumorigenesis. Oncol. Lett. 21, 356\u2013366 (2021). https:\/\/doi.org\/10.3892\/ol.2021.12617","DOI":"10.3892\/ol.2021.12617"},{"key":"1064_CR48","doi-asserted-by":"publisher","unstructured":"W. Lei, F. Liu, S.A. Ness, Positive and negative regulation of c-Myb by Cyclin D1, Cyclin-dependent kinases, and p27 Kip1. Blood 105, 3855\u20133861 (2005). https:\/\/doi.org\/10.1182\/blood-2004-08-3342","DOI":"10.1182\/blood-2004-08-3342"},{"key":"1064_CR49","doi-asserted-by":"publisher","unstructured":"J. Li, Y. Zhu, Recent advances in liver Cancer stem cells: Non-coding RNAs, oncogenes and oncoproteins. Front. Cell. Dev. Biology 8, 548335\u2013548351 (2020). https:\/\/doi.org\/10.3389\/fcell.2020.548335","DOI":"10.3389\/fcell.2020.548335"},{"key":"1064_CR50","doi-asserted-by":"publisher","unstructured":"H. Wang, P. Wang, M. Xu, X. Song, H. Wu, M. Evert, D.F. Calvisi, Y. Zeng, X. Chen, Distinct functions of transforming growth factor-\u03b2 signaling in c-MYC driven hepatocellular carcinoma initiation and progression. Cell. Death Dis. 12, 200\u2013216 (2021). https:\/\/doi.org\/10.1038\/s41419-021-03488-z","DOI":"10.1038\/s41419-021-03488-z"},{"key":"1064_CR51","doi-asserted-by":"publisher","unstructured":"K. Qu, Z. Wang, H. Fan, J. Li, J. Liu, P. Li, Z. Liang, H. An, Y. Jiang, Q. Lin, X. Dong, P. Liu, C. Liu, MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma. Cell. Death Dis. 8, e2603\u2013e2616 (2017). https:\/\/doi.org\/10.1038\/cddis.2016.352","DOI":"10.1038\/cddis.2016.352"},{"key":"1064_CR52","doi-asserted-by":"publisher","unstructured":"H. Wu, T. Reizel, Y.J. Wang, J.L. Lapiro, B.T. Kren, J. Schug, S. Rao, A. Morgan, A. Herman, L.L. Shekels, M.S. Rassette, A.N. Lane, T. Cassel, T.W.M. Fan, J.C. Manivel, S. Gunewardena, U. Apte, P. Sicinski, K.H. Kaestner, J.H. Albrecht, A negative reciprocal regulatory axis between Cyclin D1 and HNF4\u03b1 modulates cell cycle progression and metabolism in the liver. Proc. Natl. Acad. Sci. United States Am. 117, 17177\u201317186 (2020). https:\/\/doi.org\/10.1073\/pnas.2002898117","DOI":"10.1073\/pnas.2002898117"},{"key":"1064_CR53","doi-asserted-by":"publisher","unstructured":"H. Taniguchi, A. Fujimoto, H. Kono, M. Furuta, M. Fujita, H. Nakagawa, Loss-of-function mutations in Zn-finger DNA-binding domain of HNF4A cause aberrant transcriptional regulation in liver cancer. Oncotarget 9, 26144\u201326156 (2018). https:\/\/doi.org\/10.18632\/oncotarget.25456","DOI":"10.18632\/oncotarget.25456"},{"key":"1064_CR54","unstructured":"E. Tashiro, H. Maruki, Y. Minato, Y. Doki, I.B. Weinstein, M. Imoto, Overexpression of Cyclin D1 Contributes to Malignancy by Up-Regulation of Fibroblast Growth Factor Receptor 1 via the pRB\/E2F Pathway1. Cancer Research. 63, 424\u2013431 (2003)."},{"key":"1064_CR55","doi-asserted-by":"publisher","unstructured":"R.R. John, C. Ravindran, N. Malathi, R.M. Aruna, Evaluation of the role played by Cyclin D1 as a diagnostic and prognostic marker in the progression of oral carcinogenesis. J. Maxillofac. Oral Surg. 17, 389\u2013395 (2018). https:\/\/doi.org\/10.1007\/s12663-018-1087-2","DOI":"10.1007\/s12663-018-1087-2"},{"key":"1064_CR56","doi-asserted-by":"publisher","unstructured":"F.I. Montalto, F. De Amicis, Cyclin D1 in cancer: A molecular connection for cell cycle control, adhesion and invasion in tumor and stroma. Cells. 9, 2648\u20132661 (2020). https:\/\/doi.org\/10.3390\/cells9122648","DOI":"10.3390\/cells9122648"},{"key":"1064_CR57","doi-asserted-by":"publisher","unstructured":"S. Qie, J.A. Diehl, Cyclin D1, cancer progression, and opportunities in cancer treatment. J. Mol. Med. (Berl) 49, 1313\u20131326 (2016). https:\/\/doi.org\/10.1007\/s00109-016-1475-3","DOI":"10.1007\/s00109-016-1475-3"},{"key":"1064_CR58","doi-asserted-by":"publisher","unstructured":"V. D\u2019Angiolella, V. Donato, F.M. Forrester, Y.T. Jeong, C. Pellacani, Y. Kudo, A. Saraf, L. Florens, M.P. Washburn, M. Pagano, Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair. Cell. 149, 1023\u20131034 (2012). https:\/\/doi.org\/10.1016\/j.cell.2012.03.043","DOI":"10.1016\/j.cell.2012.03.043"},{"key":"1064_CR59","doi-asserted-by":"publisher","unstructured":"Q.O. Zhou, T. Liu, W. Qian, J. Ji, Q. Cai, Y. Jin, J. Jiang, J.O. Zhang, HNF4A-BAP31-VDAC1 axis synchronously regulates cell proliferation and ferroptosis in gastric cancer. Cell. Death Dis. 14, 356\u2013370 (2023). https:\/\/doi.org\/10.1038\/s41419-023-05868-z","DOI":"10.1038\/s41419-023-05868-z"},{"key":"1064_CR60","doi-asserted-by":"publisher","unstructured":"V. D\u2019Angiolella, M. Esencay, M. Pagano, A Cyclin without Cyclin-dependent kinases: Cyclin F controls genome stability through ubiquitin-mediated proteolysis. Trends Cell. Biol. 23, 135\u2013140 (2013). https:\/\/doi.org\/10.1016\/j.tcb.2012.10.011","DOI":"10.1016\/j.tcb.2012.10.011"},{"key":"1064_CR61","doi-asserted-by":"publisher","unstructured":"M. Kotulkar, D. Paine-Cabrera, K. Venneman, U. Apte, Role of HNF4alpha-cMyc interaction in liver regeneration after partial hepatectomy. Front. Endocrinol. (Lausanne) 31, 1404318\u20131404327 (2024). https:\/\/doi.org\/10.3389\/fendo.2024.1404318","DOI":"10.3389\/fendo.2024.1404318"},{"key":"1064_CR62","doi-asserted-by":"publisher","unstructured":"S. Qiu, Y. Pan, Y. Cui, M. Li, T. Yue, S. Pu, Q. Zhang, M. Wang, HNF4\u03b1 improves hepatocyte regeneration by upregulating PXR. FASEB J. 38, e23830 (2024). https:\/\/doi.org\/10.1096\/fj.202400459RR","DOI":"10.1096\/fj.202400459RR"},{"key":"1064_CR63","doi-asserted-by":"publisher","unstructured":"Z. Lin, W. Cai, Y. Sun, B. Han, Y. Hu, Z. He, X. Chen, Mechanism and application of mesenchymal stem cells and their secreting extracellular vesicles in regulating CD4(+)T cells in immune diseases. Biophys. Rep. 10, 403\u2013415 (2024). https:\/\/doi.org\/10.52601\/bpr.2024.240005","DOI":"10.52601\/bpr.2024.240005"},{"key":"1064_CR64","doi-asserted-by":"publisher","unstructured":"H. Wang, F. Chu, X.F. Zhang, P. Zhang, L.X. Li, Y.L. Zhuang, X.F. Niu, X. He, Z.J. Li, Y. Bai, D. Mao, Z.W. Liu, D.L. Zhang, B. Li, TPX2 enhances the transcription factor activation of PXR and enhances the resistance of hepatocellular carcinoma cells to antitumor drugs. Cell. Death Dis. 27, 64\u201381 (2023). https:\/\/doi.org\/10.1038\/s41419-022-05537-7","DOI":"10.1038\/s41419-022-05537-7"},{"key":"1064_CR65","doi-asserted-by":"publisher","unstructured":"J. Hou, Y. Zheng, C. Gao, Regulation of cellular senescence by innate immunity. Biophys Rep. 9, 338\u2013351 (2023). https:\/\/doi.org\/10.52601\/bpr.2023.230032","DOI":"10.52601\/bpr.2023.230032"},{"key":"1064_CR66","doi-asserted-by":"publisher","unstructured":"P.X. Li, Q. Ou, S. Shi, C. Shao, Immunomodulatory properties of mesenchymal stem cells\/dental stem cells and their therapeutic applications. Cell. Mol. Immunol. 20, 558\u2013569 (2023). https:\/\/doi.org\/10.1038\/s41423-023-00998-y","DOI":"10.1038\/s41423-023-00998-y"},{"key":"1064_CR67","doi-asserted-by":"publisher","unstructured":"O. Goldman, L.N. Adler, E. Hajaj, T. Croese, N. Darzi, S. Galai, H. Tishler, Y. Ariav, D. Lavie, L. Fellus-Alyagor, R. Oren, Y. Kuznetsov, E. David, R. Jaschek, C. Stossel, O.Singer, S. Malitsky, R. Barak, R. Seger, N. Erez, I. Amit, A. Tanay, A. Saada, T. Golan, T. Rubinek, J. Sang Lee, S. Ben-Shachar, I. Wolf, A. Erez, Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4\u03b1 and Promotes Extrahepatic Carcinogenesis. Cancer Discov. 13, 1616\u20131635 (2023). https:\/\/doi.org\/10.1158\/2159-8290.CD-22-1062","DOI":"10.1158\/2159-8290.CD-22-1062"},{"key":"1064_CR68","doi-asserted-by":"publisher","unstructured":"A. Delaforest, K. Nagaoka, K. Si-Tayeb, F.K. Noto, G. Konopka, M.A. Battle, S.A. Duncan, HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells. Development. 138, 4143\u20134153 (2011). https:\/\/doi.org\/10.1242\/dev.062547","DOI":"10.1242\/dev.062547"},{"key":"1064_CR69","doi-asserted-by":"publisher","unstructured":"A. Thakur, J.C.H. Wong, E.Y. Wang, J. Lotto, D. Kim, J.C. Cheng, M. Mingay, R. Cullum, V. Moudgil, N. Ahmed, S.H. Tsai, W. Wei, C.P. Walsh, T. Stephan, M. Bilenky, B.M. Fuglerud, M.M. Karimi, F.J. Gonzalez, M. Hirst, P.A. Hoodless, hepatocyte nuclear factor 4-Alpha is essential for the active epigenetic state at enhancers in mouse liver. Hepatol. 70, 1360\u20131376 (2019). https:\/\/doi.org\/10.1002\/hep.30631","DOI":"10.1002\/hep.30631"},{"key":"1064_CR70","doi-asserted-by":"publisher","unstructured":"D. Li, T. Zhang, Y. Guo, C. Bi, M. Liu, G. Wang, Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma. Cell. Death Dis. 15, 498\u20134103 (2024). https:\/\/doi.org\/10.1038\/s41419-024-06888-z","DOI":"10.1038\/s41419-024-06888-z"},{"key":"1064_CR71","doi-asserted-by":"publisher","unstructured":"M.W. Robinson, C. Harmon, C. O\u2019farrelly, Liver immunology and its role in inflammation and homeostasis. Cell. Mol. Immunol. 13, 267\u2013276 (2016). https:\/\/doi.org\/10.1038\/cmi.2016.3","DOI":"10.1038\/cmi.2016.3"},{"key":"1064_CR72","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s42003-024-06288-1","volume":"7","author":"C-O Ehle","year":"2024","unstructured":"C. Ehle, A. Iyer-Bierhoff, Y. Wu, S. Xing, M. Kiehntopf, A.S. Mosig, M. Godmann, T. Heinzel, Downregulation of HNF4A enables transcriptomic reprogramming during the hepatic acute-phase response. Commun. Biol. 7, 589\u20135103 (2024). https:\/\/doi.org\/10.1038\/s42003-024-06288-1","journal-title":"Commun. Biol."},{"key":"1064_CR73","doi-asserted-by":"publisher","unstructured":"S. Guo, H. Lu, Novel mechanisms of regulation of the expression and transcriptional activity of hepatocyte nuclear factor 4\u03b1. J. Cell. Biochem. 120, 519\u2013532 (2019). https:\/\/doi.org\/10.1002\/jcb.27407","DOI":"10.1002\/jcb.27407"},{"key":"1064_CR74","doi-asserted-by":"publisher","unstructured":"Y. Aydin, R. Kurt, K. Song, D. Lin, H. Osman, B. Youngquist, J.W. Scott, N.J. Shores, P. Thevenot, A. Cohen, S. Dash, Hepatic stress response in HCV infection promotes STAT3-Mediated Inhibition of HNF4A-miR-122 feedback loop in liver fibrosis and Cancer progression. Cancers (Basel). 11, 1407\u20131432 (2019). https:\/\/doi.org\/10.3390\/cancers11101407","DOI":"10.3390\/cancers11101407"},{"key":"1064_CR75","doi-asserted-by":"publisher","unstructured":"S. Park, Y.N. Ha, M. Dezhbord, A.R. Lee, E.S. Park, Y.K. Park, J. Won, N.Y. Kim, S.Y. Choo, J.J. Shin, C.H. Ahn, K.K.H. Kim, Suppression of Hepatocyte Nuclear Factor 4 \u03b1 by Long-term Infection of Hepatitis B Virus Contributes to Tumor Cell Proliferation. Int J Mol Sci. 21, 948\u2013967 (2020). https:\/\/doi.org\/10.3390\/ijms21030948","DOI":"10.3390\/ijms21030948"},{"key":"1064_CR76","doi-asserted-by":"publisher","unstructured":"T.M. Filtz, W.K. Vogel, M. Leid, Regulation of transcription factor activity by interconnected post-translational modifications. Trends Pharmacol. Sci. 35, 76\u201385 (2014). https:\/\/doi.org\/10.1016\/j.tips.2013.11.005","DOI":"10.1016\/j.tips.2013.11.005"},{"key":"1064_CR77","doi-asserted-by":"publisher","unstructured":"W. Zhou, Z. Hannoun, E. Jaffray, C.N. Medine, J.R. Black, S. Greenhough, L. Zhu, J.A. Ross, S. Forbes, I. Wilmut, J.P. Iredale, R.T. Hay, D.C. Hay, Sumoylation of HNF4\u03b1 regulates protein stability and hepatocyte function. J. Cell. Sci. 125, 3630\u20133635 (2012). https:\/\/doi.org\/10.1242\/jcs.102889","DOI":"10.1242\/jcs.102889"},{"key":"1064_CR78","doi-asserted-by":"publisher","unstructured":"B. Vet\u0151, D. Bojcsuk, C. Bacquet, J. Kiss, S. Sipeki, L. Martin, L. Buday, B.L. B\u00e1lint, T. Ar\u00e1nyi, The transcriptional activity of hepatocyte nuclear factor 4 alpha is inhibited via phosphorylation by ERK1\/2. PLoS One. e0172020\u2013e0172039 (2017). https:\/\/doi.org\/10.1371\/journal.pone.0172020","DOI":"10.1371\/journal.pone.0172020"},{"key":"1064_CR79","doi-asserted-by":"publisher","unstructured":"R. Zhang, L. Liu, Assaying antigen-specific T cell trans-endothelial migration in vitro with the transwell system: application in tumor immunology. Biophys. Rep. 10, 1\u20138 (2024). https:\/\/doi.org\/10.52601\/bpr.2024.240032","DOI":"10.52601\/bpr.2024.240032"},{"key":"1064_CR80","doi-asserted-by":"publisher","unstructured":"T. Yang, M. Poenisch, R. Khanal, Q. Hu, Z. Dai, R. Li, G. Song, Q. Yuan, Q. Yao, X. Shen, R. Taubert, B. Engel, E. Jaeckel, A. Vogel, C.S. Falk, A. Schambach, D. Gerovska, M.J. Ara\u00fazo-Bravo, F.W.R. Vondran, T. Cantz, N. Horscroft, A. Balakrishnan, F. Chevessier, M. Ott, A.D. Sharma, Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model. J. Hepatol. 75, 1420\u20131433 (2021). https:\/\/doi.org\/10.1016\/j.jhep.2021.08.011","DOI":"10.1016\/j.jhep.2021.08.011"},{"key":"1064_CR81","doi-asserted-by":"publisher","unstructured":"M. Osanai, H. Chiba, T. Kojima, M. Fujibe, K. Kuwahara, H. Kimura, M. Satoh, N. Sawada, Hepatocyte nuclear factor (HNF)-4alpha induces expression of endothelial Fas ligand (FasL) to prevent cancer cell transmigration: a novel defense mechanism of endothelium against cancer metastasis. Japanese J. Cancer Research. 93, 532\u2013541 (2002). https:\/\/doi.org\/10.1111\/j.1349-7006.2002.tb01288.x","DOI":"10.1111\/j.1349-7006.2002.tb01288.x"},{"key":"1064_CR82","doi-asserted-by":"publisher","unstructured":"P. Konyn, A. Ahmed, D. Kim, Current epidemiology in hepatocellular carcinoma. Expert Rev. Gastroenterol. Hepatol. 11, 1295\u20131307 (2021). https:\/\/doi.org\/10.1080\/17474124.2021.1991792","DOI":"10.1080\/17474124.2021.1991792"},{"key":"1064_CR83","doi-asserted-by":"publisher","unstructured":"C. Jiang, Y. Wu, J. Zhou, J. Zhao, Novel targets and small molecular interventions for liver cancer. Biomed. Res. Int. 2014, 148783\u2013148785 (2014). https:\/\/doi.org\/10.1155\/2014\/148783","DOI":"10.1155\/2014\/148783"},{"key":"1064_CR84","doi-asserted-by":"publisher","unstructured":"J. Inoue, S. Ikeda, T. Kanayama, R. Sato, The flavonoid derivative 4\u2019-nitro-6-hydroxyflavone suppresses the activity of HNF4\u03b1 and stimulates the degradation of HNF4\u03b1 protein through the activation of AMPK. Biosci. Biotechnol. Biochem. 8, 1548\u20131552 (2017). https:\/\/doi.org\/10.1080\/09168451.2017.1325316","DOI":"10.1080\/09168451.2017.1325316"},{"key":"1064_CR85","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2024.0438","author":"A Caddeo","year":"2025","unstructured":"A. Caddeo, S. Romeo, Precision medicine and nucleotide-based therapeutics to treat MASH. Clin. Mol. Hepatol. 31, (2025). https:\/\/doi.org\/10.3350\/cmh.2024.0438. S76-S93","journal-title":"Clin. Mol. Hepatol. 31"},{"key":"1064_CR86","doi-asserted-by":"publisher","unstructured":"X. Zeng, Y. Ruan, L. Wang, J. Deng, S. Yan, Synergistic Glycolysis disturbance for cancer therapy by a MOF-based nanospoiler. Biophys. Rep. 3, 134\u2013145 (2023). https:\/\/doi.org\/10.52601\/bpr.2023.230003","DOI":"10.52601\/bpr.2023.230003"},{"key":"1064_CR87","doi-asserted-by":"publisher","unstructured":"M. Sun, X. Liu, W. Wei, N. Ge, S. Luo, S. Shen, R. Ge, Retracted: BAP31 Promotes Proliferation, Invasion, and Metastasis of Liver Cancer Cells via Activating PI3K\/AKT Pathway. Journal of healthcare engineering. 11, 7686728 (2022). https:\/\/doi.org\/10.1155\/2022\/7686728","DOI":"10.1155\/2022\/7686728"},{"key":"1064_CR88","doi-asserted-by":"publisher","unstructured":"H.R. Chang, S. Nam, M.C. Kook, K.T. Kim, X. Liu, H. Yao, H.R. Jung, R. Jr. Lemos, H.H. Seo, H.S. Park, Y. Gim, D. Hong, I. Huh, Y.W. Kim, D. Tan, C.G. Liu, G. Powis, T. Park, H. Liang, Y.H. Kim, HNF4\u03b1 is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer. Gut. 2, 19\u201332 (2016). https:\/\/doi.org\/10.1136\/gutjnl-2014-307918","DOI":"10.1136\/gutjnl-2014-307918"},{"key":"1064_CR89","doi-asserted-by":"publisher","unstructured":"X. Li, Y. Huang, K. Zheng, G. Yu, Q. Wang, L. Gu, J. Li, H. Wang, W. Zhang, Y. Sun, C. Li, Integrated proteomic and phosphoproteomic data-independent acquisition data evaluate the personalized drug responses of primary and metastatic tumors in colorectal cancer. Biophys. Rep. 2, 67\u201381 (2023). https:\/\/doi.org\/10.52601\/bpr.2022.210048","DOI":"10.52601\/bpr.2022.210048"},{"key":"1064_CR90","doi-asserted-by":"publisher","unstructured":"Y. Di, W. Li, B. Salovska, Q. Ba, Z. Hu, S. Wang, Y. Liu, A basic phosphoproteomic-DIA workflow integrating precise quantification of phosphosites in systems biology. Biophys. Rep. 2, 82\u201398 (2023). https:\/\/doi.org\/10.52601\/bpr.2023.230007","DOI":"10.52601\/bpr.2023.230007"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01064-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-025-01064-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01064-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:06:13Z","timestamp":1752138373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-025-01064-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1064"],"URL":"https:\/\/doi.org\/10.1007\/s13402-025-01064-7","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"18 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}